Pamela Tenaerts

Chief Scientific Officer

As Chief Scientific Officer, Dr. Pamela Tenaerts oversees Medable’s clinical research department to help identify, develop and implement responsible decentralized trial strategies for sponsors, sites and patients. Dr. Tenaerts brings more than 30 years of experience in clinical trials, as a researcher, academic and physician, most recently serving as Executive Director of the Clinical Trials Transformation Initiative (CTTI) at Duke University.

She is a Board Member of the Society of Clinical Trials and the Scientific Leadership Council of the Digital Medicine Society and participates in the Good Clinical Trial Collaborative and the National Academies of Science and Medicine: Forum on Drug Discovery, Development and Translation. She received her MD from KU Leuven and her MBA from the University of South Florida.